Sleep apnea, or difficulty breathing at night, is common among children with Down syndrome—affecting up to 80% compared to ...

Christopher Hartnick, MD, MS, director of the Division of Pediatric Otolaryngology at Mass Eye and Ear, is the senior and ...

The first hypoglossal nerve-stimulation device (brand name Inspire) was approved by the U.S. Food and Drug Administration (FDA) in 2014 for use in patients with BMIs less than 25 whose moderate to ...

Source Reference: Patel RW, et al "Response to hypoglossal nerve stimulation changes with body mass index and supine sleep" JAMA Otolaryngol Head Neck Surg 2024; DOI: 10.1001/jamaoto.2024.0261.

Preliminary severe Obstructive Sleep Apnea data from FLOSAT study indicates opportunity for head-to-head trial between precision oral appliance therapy and hypoglossal nerve stimulationPLEASANTON ...

Hypoglossal nerve stimulation involves the implantation of a small device above the ribs, which delivers electrical impulses to the hypoglossal nerve responsible for controlling tongue muscles during ...

A sleep apnea treatment known as hypoglossal nerve stimulation is less effective in people with higher body mass indexes (BMIs), according to a new study by researchers at Washington University ...

Results from the pivotal OSPREY trial for LivaNova’s aura6000 system demonstrated promising 12-month data in patients with moderate to severe obstructive sleep apnea (OSA). According to the company, ...

Hypoglossal nerve stimulation reduced obstructive sleep apnea severity; however, this outcome was less likely among those with higher BMIs and those who slept in supine position, according to ...

PLEASANTON, Calif., July 13, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA), a leading CPAP alternative for the treatment of Obstructive Sleep Apnea (OSA), announced plans to design a head ...